Ronald Kahn, MD
Family Medicine · Kettering, OHNPI 1508843079
Payments from drug & device makers
Across 201 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Pfizer$673
- GSK$461
- Amarin Pharma, Inc.$302
- Amgen$225
- Novo Nordisk$209
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,268100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $1,272 |
| Pfizer | 42 | $673 |
| GSK | 13 | $461 |
| Amarin Pharma, Inc. | 27 | $302 |
| Amgen(2 entities) | 8 | $225 |
| Novo Nordisk | 11 | $209 |
| Boehringer Ingelheim | 14 | $194 |
| Teva Pharmaceuticals USA, Inc. | 2 | $190 |
| Sanofi-aventis U.S. LLC | 5 | $137 |
| Lilly USA, LLC | 9 | $118 |
| AbbVie(2 entities) | 5 | $83 |
| Merck | 6 | $73 |
| Johnson & Johnson | 4 | $64 |
| Novartis | 2 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Astellas Pharma US Inc | 3 | $37 |
| Mylan Specialty L.p. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Circassia Inc. | 1 | $13 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,268 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 72 | $792 |
| Gabapentin | 44 | $540 |
| Potassium Chloride | 15 | $460 |
| ClopidogrelClopidogrel Bisulfate | 15 | $370 |
| Levothyroxine Sodium | 38 | $364 |
| Lisinopril | 71 | $290 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $251 |
| Omeprazole | 26 | $223 |
| Pantoprazole Sodium | 12 | $210 |
| Metoprolol Succinate | 17 | $210 |
| Rosuvastatin Calcium | 11 | $165 |
| Amlodipine Besylate | 28 | $136 |
| Buspirone Hcl | 11 | $126 |
| Losartan Potassium | 20 | $115 |
| Furosemide | 22 | $102 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kettering
- William RandallKettering$7.5M
- Michael ButcherCincinnati$18.3M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.